QYResearch: The global procalcitonin market is expected to increase reach 212.6 g by 2023

QYResearch: The global procalcitonin market is expected to increase reach 212.6 g by 2023 QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH

www.qyresearch.com

CONTACT

Beijing Hengzhou Bozhi International Information Consulting Web: qyresearch.com | qyresearchglobal.com |

qyresearcheurope.com | qyresearch.com/english | qyresearchjapan.com TEL:+86-13660489419, Office:+86-2086655165

Media: press@qyresearch.com, Marketing: sales@qyresearch.com Facebook: @QYResearchOfficial, Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智 www.qyresearch.com

QYResearch

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin.

www.qyresearch.com

QYResearch Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection.

PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.

Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.

According to QYResearch, The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.

www.qyresearch.com

QYResearch The technical barriers of procalcitonin are high and the procalcitonin production concentrated large companies including Thermo Fisher, Roche Diagnostics, BBI Solutions, bioMerieux, etc. The top four manufacturers accounted for 25.67% in 2016.

Thermo Fisher is the largest manufacturer in the world, which production reached 12091 mg then.

The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.

The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.

www.qyresearch.com

QYResearch There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.

More Info: http://www.qyresearchglobal.com/goods-1491945.html

www.qyresearch.com